Hydrochlorothiazide Tablets USP — Class I drug recall D-1206-2018
Terminated recall by Accord Healthcare, Inc., reported 2018-09-19, distributed nationwide. Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg con
| Recall number | D-1206-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Accord Healthcare, Inc., Durham, NC, United States |
| Recall initiated | 2018-08-21 |
| Classified | 2018-09-21 |
| Reported by FDA | 2018-09-19 |
| Terminated | 2020-05-07 |
| Distributed | Nationwide (US) |
| Quantity | 46,632 bottles |
| Reason classes | labeling |
| NDC | 16729-0182, 16729-0182-01, 16729-0182-17, 16729-0183, 16729-0183-01, 16729-0183-17, 16729-0184, 16729-0184-01, 16729-0184-17 |
| Lot numbers | PW05264 |
| Expiration dates | 2019-11 |
Product
Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.
Reason for recall
Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1206-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.